{
    "clinical_study": {
        "@rank": "73799", 
        "acronym": "CO", 
        "arm_group": {
            "arm_group_label": "Safety and Adverse Reaction in CO", 
            "arm_group_type": "Experimental", 
            "description": "Inhaled Carbon Monoxide"
        }, 
        "brief_summary": {
            "textblock": "Based on the study about carbon monoxide in human inflammatory and other beneficial\n      physiological function , now we'll be going to research its application in neonates .Phase 1\n      Study as a foundation for the further test is, the safety and Adverse reaction study of\n      newborn to inhaled CO"
        }, 
        "brief_title": "The Safety and Adverse Reaction Study of Neonatal to Inhaled Carbon Monoxide", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Miscellaneous Disorders in the Fetus or Newborn", 
        "condition_browse": {
            "mesh_term": "Hypertension, Pulmonary"
        }, 
        "detailed_description": {
            "textblock": "Previous studies have demonstrated that, carbon monoxide has showed the effectiveness such\n      as in inflammation ,apoptosis as well as relaxation of smooth muscle of the body. Now we\n      have a hypothesis to use carbon monoxide in   pulmonary hypertension of the newborns, to\n      observe whether it will decrease pulmonary artery hypertension on newborns. Phase 1 study is\n      ,the safety and Adverse reaction study of newborn to inhaled CO , after this,we can master\n      the application of carbon monoxide dose"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The newborn whose physiological function is healthy or close to healthy\n\n        Exclusion Criteria:\n\n          -  Clinical considerations cannot survive or no treatment value of newborn Diagnosis of\n             congenital or hereditary diseases, or children with heart diseaseCentral pulmonary\n             vascular malformations in children"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "1 Month", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01818843", 
            "org_study_id": "DapingH 021"
        }, 
        "intervention": {
            "arm_group_label": "Safety and Adverse Reaction in CO", 
            "description": "Inhaled Carbon Monoxide in newborn", 
            "intervention_name": "Inhaled Carbon Monoxide", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Carbon Monoxide"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Carbon monoxide", 
            "safety", 
            "Adverse Reaction", 
            "newborn"
        ], 
        "lastchanged_date": "March 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "ChongQing", 
                    "country": "China", 
                    "state": "Chongqing", 
                    "zip": "400042"
                }, 
                "name": "Daping Hospital"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase 1 Study of Inhaled Carbon Monoxide on the Effectiveness of Neonatal Pulmonary Hypertension", 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number  of  participants  with  adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "up to 1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01818843"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Daping Hospital and the Research Institute of Surgery of the Third Military Medical University", 
            "investigator_full_name": "CAN WANG", 
            "investigator_title": "Phase 1 Study of Inhaled carbon monoxide on the effectiveness of neonatal pulmonary hypertension", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Daping Hospital and the Research Institute of Surgery of the Third Military Medical University", 
        "sponsors": {
            "collaborator": {
                "agency": "Daping Hospital and the Research Institute of Surgery of the Third Military Medical University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "CAN WANG", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2012"
    }
}